KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $189.44 $217.57 Friday, 26th Apr 2024 BIIB stock ended at $208.90. This is 3.18% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 5.89% from a day low at $199.10 to a day high of $210.82.
90 days $189.44 $251.99
52 weeks $189.44 $319.76

Historical Biogen Inc. prices

Date Open High Low Close Volume
Mar 04, 2016 $269.64 $269.68 $263.13 $263.94 1 635 400
Mar 03, 2016 $272.22 $272.82 $266.14 $268.64 1 430 900
Mar 02, 2016 $270.17 $274.57 $268.66 $273.66 1 651 000
Mar 01, 2016 $261.37 $271.01 $259.25 $270.90 1 924 300
Feb 29, 2016 $262.68 $265.60 $259.18 $259.42 1 766 500
Feb 26, 2016 $264.06 $266.47 $260.88 $264.49 1 603 200
Feb 25, 2016 $261.90 $262.84 $259.16 $262.35 1 516 000
Feb 24, 2016 $256.35 $257.68 $249.01 $257.22 1 427 700
Feb 23, 2016 $264.81 $265.86 $257.90 $258.99 1 530 200
Feb 22, 2016 $265.26 $266.00 $261.34 $265.83 1 217 000
Feb 19, 2016 $257.36 $263.00 $255.12 $261.40 1 448 000
Feb 18, 2016 $266.60 $266.96 $258.51 $259.05 1 522 400
Feb 17, 2016 $256.29 $265.86 $256.08 $265.63 1 908 900
Feb 16, 2016 $249.00 $257.42 $249.00 $256.52 2 069 700
Feb 12, 2016 $248.78 $249.20 $242.07 $247.22 2 110 700
Feb 11, 2016 $246.31 $250.02 $243.03 $245.11 2 162 100
Feb 10, 2016 $253.35 $257.37 $249.28 $252.20 1 745 100
Feb 09, 2016 $246.54 $255.00 $243.85 $249.99 2 362 600
Feb 08, 2016 $260.45 $260.45 $248.16 $250.77 2 741 600
Feb 05, 2016 $271.10 $272.67 $258.46 $263.86 2 836 800
Feb 04, 2016 $270.16 $279.38 $269.11 $273.27 2 067 500
Feb 03, 2016 $267.58 $270.74 $261.00 $270.43 2 085 800
Feb 02, 2016 $267.74 $271.20 $265.16 $266.06 1 920 200
Feb 01, 2016 $270.34 $275.83 $269.58 $273.45 1 842 500
Jan 29, 2016 $268.42 $273.90 $265.70 $273.06 3 067 900
Click to get the best stock tips daily for free!

About Biogen Inc.

Biogen. Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; ADUHELM for the treatment of Alzheimer's disease; IMRALDI, an ad... BIIB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT